NCT06302946 Effect of Neuromuscular Stimulation and Mindfulness Exercise in Patients With Stroke
| NCT ID | NCT06302946 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-03-15 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is an interventional study in which 60 stroke patients were estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness , while the control group will receive neuromuscular stimulation only.
Eligibility Criteria
Inclusion Criteria: * The subject selection will be according to the following criteria: * All Patients of this study will be diagnosed as stroke and the diagnosis will be confirmed by computed tomography or MRI (El-Tamawy et al., 2021). * Age of patients will be ranged from 50 to 65years (males and females). * All patients will be hemodynamically stable. * Patients with good cognition that enables them to understand the requirements of the study. Exclusion Criteria: * • The potential participants will be excluded if they meet one of the following criteria: * Patients who cannot follow instructions as sensory aphasia, blindness, dementia, and deafness. * Patients with any orthopedic, neurological, or chest disorders that affect trunk muscles control or cause respiratory disorders as COPD. * Patients with cognitive and psychiatric disorders. * Patients with unstable cardiovascular conditions. * Patients with contraindications to neuro electrical stimulation as: * Cardiac pace maker. * Acute abdominal surgery.
Contact & Investigator
marwa elsayed
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06302946 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 65 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06302946 currently recruiting?
Yes, NCT06302946 is actively recruiting participants. Contact the research team at marwa.elsaid@cu.edu.eg for enrollment information.
Where is the NCT06302946 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06302946 clinical trial?
NCT06302946 is sponsored by Cairo University. The principal investigator is marwa elsayed at Cairo University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.